HRT Financial LP Sells Shares of CMND $CMND
Key Points
- HRT Financial LP sold 225,191 shares of Clearmind Medicine Inc. ($CMND) worth $27,023.
- $CMND last traded around $3.34.
HRT Financial LP, insider at Clearmind Medicine Inc. ($CMND), sold 225,191 shares at an average price of $0.12, for a total transaction of $27,023. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission.
Clearmind Medicine Inc. ($CMND) Stock
Clearmind Medicine Inc. Earnings
About Clearmind Medicine Inc.
Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. It develops MEAI compound for the treatment of alcohol use disorder, obesity, and metabolic disorders, as well as an alcohol substitute consumer product; and CM-CMND-001 which is in Phase I/IIa clinical trial for the treatment of alcohol use disorder. In addition, the company has a strategic collaboration with SciSparc Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem, Polyrizon Ltd., and NeuroThera Labs Inc. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.
See Also
This instant news alert was generated by automated narrative technology and financial data from Trueearnings and public regulatory filings. It is for informational purposes only and is not financial advice.